Previous Close | 11.00 |
Open | 11.00 |
Bid | 14.50 |
Ask | 17.80 |
Strike | 35.00 |
Expire Date | 2024-06-21 |
Day's Range | 11.00 - 11.00 |
Contract Range | N/A |
Volume | |
Open Interest | 18 |
SOUTH SAN FRANCISCO, Calif., June 06, 2024--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the publication of a study detailing the discovery of TB206-001, a first-in-class antibody targeting adenosine A2A receptor (A2AR), a promising molecular target that could enhance cancer immunotherapy. The study titled, "Discovery of a potent, selective, and tumor-suppressing
SOUTH SAN FRANCISCO, Calif., June 04, 2024--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that the company has joined the U.S. AI Safety Institute Consortium (AISIC), a group established by the Department of Commerce’s National Institute of Standards and Technology (NIST) to support the development and deployment of trustworthy and safe AI.
This online drug provider will offer an online weight loss drug but the stock sank soon after it jumped. A Cathie Wood biotech stock also gave back gains.